Evidence map›Paper›PMID 41346409›Full record

ReviewArrhythmia & electrophysiology review2025

The Global Impact of Atrial Fibrillation.

Maham F Karatela, Hugh Calkins

Abstract readReview
In one paragraph

Review in Arrhythmia & electrophysiology review, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Colchicine initiated before radiofrequency-induced injury attenuates left atrial inflammation, fibrosis, and susceptibility to atrial fibrillation.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Atrial Cardiomyopathy.Maedica · 2026
    Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. mCardiacDx: Radar-Driven Contactless Monitoring and Diagnosis of Atrial Fibrillation.IEEE journal of translational engineering in health and medicine · 2026
    Article
  12. Review
  13. Ibutilide: what's clinically proven, what's being investigated?Indian pacing and electrophysiology journal
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Maham F KaratelaDivision of Cardiology, Department of Medicine, Johns Hopkins Hospital Baltimore, MD, US.
Hugh CalkinsDivision of Cardiology, Department of Medicine, Johns Hopkins Hospital Baltimore, MD, US.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

AF is a common yet multifaceted cardiac arrhythmia with a far-reaching impact. The global burden of AF has been growing rapidly over the last few decades, partly related to the increasing overall burden of chronic illnesses in the setting of an ageing world population. Not only is AF common, but it also has significant implications for patients' health. There exist regional variations in the incidence, prevalence, morbidity and mortality of AF. Moreover, treatment strategies differ appreciably by global regions in a pattern influenced by regional differences in access to medications, the development of large-volume centres and the presence of clinical research. This review explores how AF epidemiology has evolved over time with distinct geographic heterogeneity, and it aims to provide an updated context for the global impact of AF.

Indexed as

AFburdenepidemiologyglobalincidenceprevalence

Identifiers

PMID41346409
PMCPMC12673497

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.